Greater occipital nerve blockade for the preventive treatment of chronic migraine: A randomized double-blind placebo-controlled study.
PAPERS | February 4-10, 2023 | |
Source: Cephalalgia 2023 Feb; 43(2). doi: 10.1177/03331024221143541Authors: Chowdhury D, Tomar A, Deorari V, Duggal A, Krishnan A, Koul A
Greater occipital nerve blockade for the prevention of chronic migraine has a limited evidence base. A robust randomized double-blind, placebo-controlled trial is needed.
Pubmed ID: https://pubmed.ncbi.nlm.nih.gov/36739512/